Interleukin 2 treatment in HIV-1 infection.

Interleukin 2 treatment in HIV-1 infection.

Bibliographic Details
Main Author:	Angus, B
Format:	Journal article
Language:	English
Published:	2006

Similar Items

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
by: Angus, B, et al.
Published: (2008)

Association of interleukin-10 promoter genetic variants with T-cell and B-cell activation in HIV-1 infection
by: Naicker, D, et al.
Published: (2012)

Novel agents for the treatment of HIV-2 infection.
by: Peterson, K, et al.
Published: (2012)

Effect of HIV-2 infection on HIV-1 disease progression.
by: de Silva, T, et al.
Published: (2012)

Treatment interruption in chronic HIV-1 infection: does it deliver?
by: Willberg, C, et al.
Published: (2007)

Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection
by: Ndhlovu, Zaza M., et al.
Published: (2020)

Immune control of HIV-1 after early treatment of acute infection.
by: Rosenberg, E, et al.
Published: (2000)

Proliferation, but not interleukin 2 production, of Gag-specific CD8+ T cells is associated with low HIV viremia and high CD4 counts in HIV-1-infected Chinese individuals.
by: Li, H, et al.
Published: (2009)

Acute HIV-1 infection
by: Cohen, MS, et al.
Published: (2011)

Acute HIV-1 Infection.
by: Cohen, MS, et al.
Published: (2011)

Impact of inflammatory interleukin-1 genotypes on risk of infection in UK Biobank
by: Camm, C, et al.
Published: (2017)

Treatment of latent tuberculosis infection in HIV infected persons.
by: Akolo, C, et al.
Published: (2010)

Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.
by: Nyamweya, S, et al.
Published: (2013)

Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis
by: Nyamweya, S, et al.
Published: (2013)

HIV-1 transmission and acute HIV-1 infection.
by: Hansasuta, P, et al.
Published: (2001)

Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: The role of interleukin 7 and interleukin 7 receptor alpha and microbial translocatioa
by: Rajasuriar, R., et al.
Published: (2010)

The protective effect of HIV-2 infection: implications for understanding HIV-1 immunity.
by: Kanki, P, et al.
Published: (2014)

HIV-specific interleukin-10 responses and immune modulation
by: Clutton, G
Published: (2012)

Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.
by: Duvall, MG, et al.
Published: (2007)

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.
by: Jobarteh, M, et al.
Published: (2010)

Protective immunity against HIV infection: lessons from HIV-2 infection.
by: Rowland-Jones, S
Published: (2006)

Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.
by: Deleuran, B, et al.
Published: (1992)

Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.
by: Duvall, MG, et al.
Published: (2006)

Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection.
by: Yang, H, et al.
Published: (2013)

Improved quantification of HIV-1-infected CD4+ T cells using an optimised method of intracellular HIV-1 gag p24 antigen detection
by: Yang, H, et al.
Published: (2013)

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia.
by: Peterson, I, et al.
Published: (2011)

Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia
by: Peterson, I, et al.
Published: (2011)

Influence of HIV-1 specific T cell response on the progression of HIV-1 infection
by: Zhang, Y, et al.
Published: (2009)

Viral genetics of HIV-2 infection
by: James, K
Published: (2015)

Targeting Interleukin-18 (IL-18) in malaria infection
by: Basir, Rusliza, et al.
Published: (2009)

Effects of interleukin-18 modulation on the pathogenesis of malaria infection
by: Jabbarzare, Marzieh
Published: (2013)

Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa
by: Okomo, U, et al.
Published: (2012)

Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
by: Okomo, U, et al.
Published: (2012)

Interleukin-1 and susceptibility to ankylosing spondylitis
by: Edwards, S, et al.
Published: (2001)

HIV-1 Vpu represents a minor target for cytotoxic T lymphocytes in HIV-1-infection.
by: Addo, M, et al.
Published: (2002)

Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
by: Lopes, A, et al.
Published: (2003)

Innate immunity in acute HIV-1 infection
by: Borrow, P
Published: (2011)

Innate immunity in acute HIV-1 infection.
by: Borrow, P
Published: (2011)

Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis.
by: Kristensen, M, et al.
Published: (1992)

Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?
by: Nyamweya, S, et al.
Published: (2012)